Imidazolin-2-ylaminophenyl amides as ip antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 233/50 (2006.01) A61K 31/4168 (2006.01) A61P 11/00 (2006.01) A61P 13/02 (2006.01) A61P 29/00 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01)

Patent

CA 2522817

Compounds effective as IP receptor modulators, particularly IP receptor antagonists, that are of the formula I: wherein A, R1 and R2 are as defined in the specification; and individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.

L'invention concerne des composés efficaces comme modulateurs du récepteur IP, en particulier comme antagonistes du récepteur IP, qui présentent la formule (I) dans laquelle A, R?1¿ et R?2¿ sont définis comme dans la spécification, ainsi que des isomères individuels, des mélanges racémiques ou non racémiques d'isomères et leurs sels ou solvates pharmaceutiquement acceptables. L'invention concerne également des compostions pharmaceutiques contenant lesdits composés et des méthodes permettant de les utiliser comme agents thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazolin-2-ylaminophenyl amides as ip antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazolin-2-ylaminophenyl amides as ip antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolin-2-ylaminophenyl amides as ip antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1579303

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.